Effects of Mass Drug Administration of Azithromycin on Mortality and Other Outcomes Among 1-11 Month Old Infants in Mali (LAKANA)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04424511 |
|
Recruitment Status :
Recruiting
First Posted : June 11, 2020
Last Update Posted : October 6, 2022
|
Sponsor:
Tampere University
Collaborators:
Center for Vaccine Development CVD-Mali, Bamako, Mali
University College London Hospitals
Tro Da Ltd, UK
Duke-NUS Graduate Medical School
Bill and Melinda Gates Foundation (Funder)
Pfizer Inc. (Provider of study drugs)
Information provided by (Responsible Party):
Per Ashorn, Tampere University
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | June 30, 2024 |
| Estimated Study Completion Date : | December 31, 2024 |